KEWAUNEE SCIENTIFIC CORP /DE/
KEQUNasdaqIndustrials · Laboratory Apparatus & Furniture · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $240.5M | $203.8M | $219.5M | $168.9M | $33.3M | $36.4M |
| Operating income | $17.8M | $18.3M | $5.4M | −$2.6M | −$1.3M | −$2.3M |
| Net income | $11.4M | $18.8M | $738,000 | −$6.1M | $81,000 | −$598,000 |
| Total assets | $194.7M | $134.8M | $118.9M | $118.8M | $89.4M | $83.9M |
| Total liabilities | $128.4M | $78.6M | $80.4M | $82.6M | $47.9M | $45.2M |
| Equity | $64.5M | $54.8M | $37.4M | $35.7M | $41.2M | $38.4M |
| EPS (diluted) | $3.83 | $6.38 | $0.25 | $-2.20 | $0.03 | $-0.22 |
| Shares out. | 2.8M | 2.8M | 2.9M | 2.8M | 2.8M | 2.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 7.4%
- Net margin
- 4.7%
- Return on equity
- 17.7%
- Return on assets
- 5.9%
- Return on capital (ROCE)
- 12.6%
- Liabilities / assets
- 66.0%
- Debt / equity
- 1.99×
- Book value / share
- $22.66
- Revenue growth (YoY)
- 18.0%
- Net income growth (YoY)
- −39.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 4.31safe
- Accruals / assets
- −1.7%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 6 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Dec 15, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Campbell John JetteDirector | May 1, 2026 | Grant | 2,013 | $0.00 |
| Gehl Keith MDirector | May 1, 2026 | Grant | 2,013 | $0.00 |
| Pyle Margaret BDirector | Mar 26, 2026 | Gift | 2,750 | $0.00 |
| Hull Thomas David IiiOfficer — President, CEO | Jan 7, 2026 | Sell | 2,177 | $37.50 |
| Gardner Donald T. IiiOfficer — Chief Financial Officer | Jan 6, 2026 | Sell | 2,000 | $37.57 |
| Hull Thomas David IiiOfficer — President, CEO | Dec 30, 2025 | Sell | 29 | $38.00 |
| Hull Thomas David IiiOfficer — President, CEO | Dec 29, 2025 | Sell | 884 | $38.01 |
| Hull Thomas David IiiOfficer — President, CEO | Dec 22, 2025 | Sell | 1,000 | $39.00 |
| Hull Thomas David IiiOfficer — President, CEO | Dec 17, 2025 | Sell | 1,000 | $39.00 |
| Gardner Donald T. IiiOfficer — Chief Financial Officer | Oct 9, 2025 | Sell | 3,000 | $42.76 |
| Phillips Elizabeth DOfficer — VP - Human Resources | Oct 2, 2025 | Sell | 6,877 | $43.20 |
| Hull Thomas David IiiOfficer — President, CEO | Oct 1, 2025 | Sell | 1,000 | $43.09 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 42,390 | 22.0 | -5.7% |
| Apr 30, 2026 | 44,928 | 18.3 | +7.1% |
| Apr 15, 2026 | 41,941 | 11.4 | +5.8% |
| Mar 31, 2026 | 39,659 | 7.0 | +18.4% |
| Mar 13, 2026 | 33,510 | 3.3 | -1.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMar 11, 2026
- Other material eventFeb 25, 2026
- Results of operationsDec 10, 2025
- Entered a material agreement · Terminated a material agreement · New financial obligation · Regulation FD disclosureDec 4, 2025
- Other material eventNov 26, 2025
- Director / officer change · Amended charter or bylawsSep 11, 2025
- Results of operationsSep 10, 2025
- Shareholder voteAug 29, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.